A detailed history of Apollon Wealth Management, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Apollon Wealth Management, LLC holds 18,405 shares of DXCM stock, worth $1.4 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,405
Previous 22,143 16.88%
Holding current value
$1.4 Million
Previous $2.51 Million 50.88%
% of portfolio
0.04%
Previous 0.08%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$64.0 - $116.06 $239,232 - $433,832
-3,738 Reduced 16.88%
18,405 $1.23 Million
Q2 2024

Jul 19, 2024

BUY
$110.31 - $140.45 $17,980 - $22,893
163 Added 0.74%
22,143 $2.51 Million
Q1 2024

May 02, 2024

BUY
$114.22 - $140.1 $685 - $840
6 Added 0.03%
21,980 $3.05 Million
Q4 2023

Feb 06, 2024

SELL
$75.49 - $124.16 $52,541 - $86,415
-696 Reduced 3.07%
21,974 $2.73 Million
Q3 2023

Nov 14, 2023

BUY
$86.06 - $137.93 $93,977 - $150,619
1,092 Added 5.06%
22,670 $2.12 Million
Q2 2023

Aug 04, 2023

SELL
$112.47 - $130.98 $276,226 - $321,686
-2,456 Reduced 10.22%
21,578 $2.77 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $67,912 - $80,266
-653 Reduced 2.65%
24,034 $2.79 Million
Q4 2022

Feb 15, 2023

SELL
$84.98 - $122.67 $49,543 - $71,516
-583 Reduced 2.31%
24,687 $2.8 Million
Q3 2022

Nov 08, 2022

BUY
$76.35 - $94.18 $107,882 - $133,076
1,413 Added 5.92%
25,270 $2.04 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $1.21 Million - $2.37 Million
17,865 Added 298.15%
23,857 $1.78 Million
Q1 2022

May 16, 2022

BUY
$94.08 - $130.2 $330,126 - $456,871
3,509 Added 141.32%
5,992 $3.07 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $322,467 - $404,282
2,483 New
2,483 $268,000
Q3 2020

Nov 03, 2020

SELL
$95.51 - $112.95 $5,253 - $6,212
-55 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $3,447 - $5,793
55 New
55 $22,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Apollon Wealth Management, LLC Portfolio

Follow Apollon Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apollon Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apollon Wealth Management, LLC with notifications on news.